Navigation Links
Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B
Date:12/6/2010

DNA. Participants received no immune suppressing drugs prior to infusion of the experimental vector.

Results so far suggest the experimental vector does not trigger the T-cell mediated immune response seen in a previous hemophilia B gene therapy trial.

The third and highest dose of the novel gene-vector combination is scheduled to be infused into the fifth and sixth study participants by mid-January. Investigators will then decide whether to expand the trial to include four more adults with severe hemophilia B. Study participants were all recruited at UCL/Royal Free Hospital through the efforts of co-author Edward G.D. Tuddenham, M.D.

Davidoff and Nathwani noted that hemophilia B has been the main focus of gene therapy efforts for disorders affecting the liver because the threshold required for therapeutic effect is modest. In patients with severe hemophilia B whose baseline level of Factor IX is less than 1 percent, generating expression of just 5 percent has the potential to dramatically affect their quality of life, reducing disabling and painful episodes of bleeding and eliminating the need for costly infusions of the protein.

Factor IX is needed for normal clot formation. A mutation in the gene that carries instructions for assembling the protein leaves about 1 in 30,000 individuals at risk for disabling episodes of internal and external bleeding. The gene is carried on the X chromosome, and the disorder is almost exclusively a male disease.

The trial vector was made at the Children's Good Manufacturing Practices (GMP), LLC, facility, on the St. Jude campus. The GMP operates under government-approved manufacturing guidelines and produces the highly specialized medicines and vaccines that pharmaceutical companies are reluctant to pursue.


'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2

Related biology news :

1. SomaLogic researchers describe revolutionary new approach to protein analysis and application to early diagnosis of lung cancer
2. U of M researcher helps unlock 30 new genes responsible for early onset puberty
3. UGA researchers identify key enzyme that regulates the early growth of breast cancer cells
4. PAREXEL Completes 200 Patient Studies In Its Early Phase Units Over Three Years
5. Arsenic early in treatment improves survival for leukemia patients
6. Brookhaven chemist Jacob Hooker receives Presidential Early Career Award
7. Studying the metabolome of smokers, Lombardi researchers find early signs of damage
8. UV light nearly doubles vacuums effectiveness in reducing carpet microbes
9. Found: First complete remains of early sauropod dinosaur
10. Early role of mitochondria in AD may help explain limitations to current beta amyloid hypothesis
11. JCI online early table of contents: Oct. 11, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... consume the healthcare community and remain priority ... To address the worldwide crisis of obesity ... global leaders in diabetes, epidemiology and public ... and development of diverse intervention programs in ... This book on "Global Health Perspectives in ...
(Date:7/25/2014)... University of Adelaide has opened the way for the development ... , In Australia, annual barley production is second only to ... one of the most important diseases of barley. , Senior ... composition of special growths on the cell walls of barley ... leaf. , The research, by the ARC Centre of Excellence ...
(Date:7/25/2014)... pleiotropic factor characterized by the existence of numerous ... confer to the protein deeply different characteristics. NRG1 ... occurring during development and the different phases occurring ... axon regrowth, remyelination and target reinnervation, Researchers at ... the soluble NRG1 upregulation observed in Schwann cells ...
Breaking Biology News(10 mins):What constitutes an effective response to the global 'diabesity' tsunami? 2New hope for powdery mildew resistant barley 2
... contamination of drinking water does not have a ... of Wisconsin-Madison researchers on arsenic-tainted wells shows that ... the contamination. Naturally occurring arsenic in rocks ... where it poses no threat to groundwater, explains ...
... maps that allow conservationists to estimate the distribution of ... threatened species and those with specific habitats, according to ... Conservation Biology. Our study found that species ranges ... trend is particularly pronounced for birds that are threatened, ...
... dinosaur from the Early Jurassic has been discovered in ... Glacialisaurus hammeri and lived about 190 million years ago. ... is based on partial foot, leg and ankle bones ... Antarctica at an elevation of more than 13,000 feet. ...
Cached Biology News:Arsenic contamination lacks one-size-fits-all remedy 2Arsenic contamination lacks one-size-fits-all remedy 3Threatened birds may be rarer than geographic range maps suggest 2Threatened birds may be rarer than geographic range maps suggest 3Massive dinosaur discovered in Antarctica sheds light on life, distribution of sauropodomorphs 2
(Date:7/24/2014)... Yan, Distinguished Professor of Engineering at the University ... to solve problems in energy engineering, environmental sustainability ... on zeolites, porous rock with a well-defined, crystalline ... is so precisely decided that zeolites can separate ... of an angstrom (one-tenth of a nanometer), making ...
(Date:7/24/2014)... 24, 2014 Your cell phone ... modeling lithium-ion battery storage capacity. , New research ... theoretical model created at Lawrence Livermore National ... predicts how carbon components will perform as electrodes. ... the urgent need for higher-performance batteries. Several key ...
(Date:7/24/2014)... 24, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Sulphate basic information, including its definition, classification, ... This research covers the international market analysis, including ... analysis covering macroeconomic environment & economic situation analysis, ...
(Date:7/24/2014)... The first part of the session on “Best ... Studies” will cover comprehensive clinical support in early phase ... R&D costs and declining industry success in getting products ... collected in early Phase I/IIa study data to make ... development. , Next, the presenters will examine steps to ...
Breaking Biology Technology:University of Delaware researcher describes new approach for creating organic zeolites 2Getting More Life out of Lithium-ion Batteries 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... Jan. 29 CuraGen Corporation (Nasdaq: CRGN ), ... and calendar year of 2008 and provided milestone and ... three month period ended December 31, 2008, CuraGen utilized ... fourth quarter with $88 million of cash and investments. ...
... development and production, today announced the appointment of David Pyrce as its ... ... Los Angeles (PRWEB) January 29, 2009 -- Nexsun Corp, a leader in ... David Pyrce as its Chief Executive Officer and member of the Board ...
... (Nasdaq: SGMO ) today announced that the ... financial results on Wednesday, February 4, 2009, after the ... a conference call at 5:00 p.m. ET, which will ... During the conference call, the company will review the ...
Cached Biology Technology:CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 2CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 3CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 4CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 5CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 6Nexsun Corp Names Industry Executive David Pyrce as Chief Executive Officer 2Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast 2Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast 3
For the quantitative determination of cyclic AMP (cAMP) concentrations in cell culture supernates, serum, plasma, saliva, urine and cell lysates....
FRACTALKINE [Human] (Recombinant)...
... head automatically rises at the end of determination; triple-point calibration verification; refrigerator eliminates need for pumps and bath ... * ... ... ...
... The Luminex® 200 System with ... for developing single and multi-analyte assays ... contains the new, powerful user friendly ... user can design specific templates for ...
Biology Products: